Thank you This live web event has ended. Thank you for attending. Contributors Peter Llewellyn, Managing Director, NetworkPharma Ltd. and Founder of the MedComms Networking Community With a background in pharma, e-comms, marketing, medical communications and publishing work, Peter is now involved in a diverse range of activities. MedComms Networking, which celebrated its 10 year anniversary in 2017, is a global initiative that facilitates networking and dialogue amongst individuals working in and around the pharmaceutical industry and MedComms, focusing on specialist medical education, medical communications and medical publishing activities. Dr. Genevieve Chase, Client Services Lead, HealthCare21 Singapore Genevieve has over 20 years’ experience spanning research, publications, medical writing, project management and supervision, protocol development, education and client liaison in academia and the pharmaceutical industry. She gained her PhD in Australia then carried out postdoctoral research in the US, before moving to Singapore to work in MedComms. This background has provided her with extensive experience in many therapeutic areas, including aesthetics, cardiovascular disease, diabetes, multiple sclerosis, oncology, pain and vaccines, and an abundance of healthcare knowledge in developing and emerging markets. Dr. Sally Stringer, Scientific Director, HealthCare21 Communications Sally is responsible for ensuring that the medical communication and education delivered by her team of writers and editors has the right strategic medical and scientific messages and is of the highest quality. This includes a variety of engaging approaches, such as virtual advisory boards and learning platforms, web workshops, animations and infographics, aimed at improving management and treatment of patients with long-term conditions. Her role has included working with emerging markets where she has gained insights into the challenges met by local physicians. Prior to her seven years in the industry, Sally was a research team leader and lecturer, has over 30 publications drawn from her own research, and has worked as an Assistant Professor in the US and Australia. Stephen Doyle, GM Head of China and Global Head of Commercial Operations, ASLAN Pharmaceuticals Stephen has 20 years’ experience in sales and marketing across different specialties within the medical sector in both developed and emerging markets. Career highlights include driving study concepts through inception, clinical development, publication, regulatory and health board approval in-market; lifecycle management success in bringing unique indication extension to products in China; and extensive experience in all aspects of change management demonstrated by the successful integration, management and reorganisation of Genzyme with Sanofi in China, and Aventis with Sanofi in Australia. Stephen has been a teacher of pharmaceutical marketing within the Medical Affairs China development programme, a commercial expert and lecturer at biosimilar conferences in China, and is also a passionate oncology advocate currently serving on the board of the CEO Roundtable on Cancer in China. Peter West, Chief Executive Officer, Academy of Infection Management Peter is the founder and Chief Executive Officer of a not-for-profit Infectious Disease society, the Academy of Infection Management, (AIM) Ltd. AIM provides medical education resources for healthcare professionals with an interest in infectious disease and is supported by a global Faculty of some of the leading clinicians in this field. AIM works with other medical societies, the pharmaceutical industry and various government and regulatory authorities on programmes relating to infectious disease. Peter has a background in the pharmaceutical industry spanning over 25 years. This includes a number of senior Executive roles, including General Manager of AstraZeneca, Romania, and Senior Marketing Director for anti-infectives at Wyeth Pharmaceuticals, responsible for activities in Europe, Middle East, Africa and Canada. Since 2010, Peter has worked as a freelance consultant, providing strategic and operational support to small biotech and major pharmaceutical companies.